Encoding Immune-Modulation Within mRNA Vaccines Against the Model Flavivirus, West Nile Virus

Grants and Contracts Details

StatusActive
Effective start/end date12/17/24 → 12/16/26

Funding

  • Merck Sharp & Dohme Corporation: $564,367.00